# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Mizuho analyst Christopher Parkinson maintains FMC (NYSE:FMC) with a Outperform and lowers the price target from $49 to $39.
UBS analyst Joshua Spector maintains FMC (NYSE:FMC) with a Neutral and lowers the price target from $44 to $36.
Citigroup analyst Patrick Cunningham maintains FMC (NYSE:FMC) with a Neutral and lowers the price target from $42 to $34.
Barclays analyst Benjamin Theurer maintains FMC (NYSE:FMC) with a Overweight and lowers the price target from $49 to $48.
RBC Capital analyst Arun Viswanathan maintains FMC (NYSE:FMC) with a Sector Perform and lowers the price target from $47 to ...